.jpg?format=webp&width=780)
Patients with cancer (patients with a history of cancer) with advanced heart failure are increasing but unlikely to be transplanted. A left ventricular assist device (LVAD) is an alternative strategy. This study investigates the characteristics and outcomes of patients with cancer undergoing durable LVAD. Overall, 1273 (6.5%) patients had a history of cancer, including 289 (22.7%) with CCM and 984 (77.3%) with non-CCM as the primary reason for heart failure. A history of cancer is associated with mildly reduced survival, lower incidence of heart transplantation, and increased risk of bleeding after LVAD, whereas the survival in patients with cancer with CCM-induced heart failure, is similar to those without cancer. LVAD implantation in patients with cancer is very well possible.
Like
Save
Share